Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 57,490 | 4,231,206 | 4,413,702 | -658,963 | -327,845 |
| Depreciation Amortization | 4,883 | 22,036 | 16,811 | 11,426 | 5,839 |
| Accounts payable and accrued liabilities | -25,267 | 22,684 | 1,797 | 10,142 | 11,940 |
| Other Working Capital | -68,735 | 19,035 | 3,080 | -18,115 | -35,242 |
| Other Operating Activity | -161,200 | -5,060,229 | -5,092,201 | 209,151 | 95,376 |
| Operating Cash Flow | $-192,829 | $-765,268 | $-656,811 | $-446,359 | $-249,932 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -965 | -1,382 | -1,033 | -678 | -403 |
| Net Acquisitions | N/A | 5,196,413 | 5,197,217 | -36,179 | N/A |
| Other Investing Activity | 0 | 8,592 | 511 | 511 | 508 |
| Investing Cash Flow | $-965 | $5,203,623 | $5,196,695 | $-36,346 | $105 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,500 | -29,158 | -21,815 | -14,471 | -7,344 |
| Common Stock Issued | 2,271 | 493,825 | 490,170 | 242,556 | 21,028 |
| Common Stock Repurchased | -648,385 | -41 | -41 | -41 | N/A |
| Dividend Paid | N/A | -6,000 | -6,000 | -6,000 | N/A |
| Other Financing Activity | -13,002 | -39,262 | -10,326 | -6,695 | -6,207 |
| Financing Cash Flow | $-660,616 | $419,364 | $451,988 | $215,349 | $7,477 |
| Exchange Rate Effect | -2,740 | 616 | 1,471 | -1,571 | -117 |
| Beginning Cash Position | 6,550,450 | 1,692,115 | 1,692,115 | 1,692,115 | 1,692,115 |
| End Cash Position | 5,693,300 | 6,550,450 | 6,685,458 | 1,423,188 | 1,449,648 |
| Net Cash Flow | $-857,150 | $4,858,335 | $4,993,343 | $-268,927 | $-242,467 |
| Free Cash Flow | |||||
| Operating Cash Flow | -192,829 | -765,268 | -656,811 | -446,359 | -249,932 |
| Capital Expenditure | -965 | -1,382 | -1,033 | -678 | -403 |
| Free Cash Flow | -193,794 | -766,650 | -657,844 | -447,037 | -250,335 |